Edition:
United Kingdom

SAGE Therapeutics Inc (SAGE.OQ)

SAGE.OQ on NASDAQ Stock Exchange Global Market

139.79USD
18 Jan 2019
Change (% chg)

-- (--)
Prev Close
$139.79
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
173,881
52-wk High
$195.97
52-wk Low
$79.90

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -2.632
Jun '18 90.00 -0.365
Mar '18 0.00 -1.683
FY 2017 Dec '17 0.00 -1.720
Sep '17 0.00 -1.967
Jun '17 0.00 -1.879
Mar '17 0.00 -1.523
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 10 0.67 5.07 0.00 --
Quarter Ending Jun-19 11 3.68 8.44 0.00 --
Year Ending Dec-19 17 34.02 113.45 7.20 59.57
Earnings (per share)
Quarter Ending Mar-19 8 -3.04 -2.75 -3.45 --
Quarter Ending Jun-19 8 -3.11 -2.75 -3.60 --
Year Ending Dec-19 16 -10.86 -7.56 -13.69 -6.91
LT Growth Rate (%) 1 13.10 13.10 13.10 -15.20
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.71 33.71
P/E High - Last 5 Yrs. -- 148.01 49.93
P/E Low - Last 5 Yrs. -- 47.79 24.27
Beta -- 1.08 0.90
Price to Sales (TTM) -- 49.51 6.28
Price to Book (MRQ) 9.22 10.16 5.27
Price to Tangible Book (MRQ) 9.22 13.82 6.79
Price to Cash Flow (TTM) -- 52.80 24.84
% Owned Institutions -- 3.75 1.69

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.40
Dividend Yield - 5 Year Avg -- 0.09 1.42
Dividend 5 Year Growth Rate -- 0.79 4.83
Payout Ratio(TTM) -- 7.04 41.08

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 130.03 9.72
Sales (TTM) vs TTM 1 Yr. Ago -- 47.85 5.87
Sales - 5 Yr. Growth Rate -- 22.76 11.20
EPS (MRQ) vs Qtr. 1 Yr. Ago -73.38 75.87 47.26
EPS (TTM) vs TTM 1 Yr. Ago -55.99 -- --
EPS - 5 Yr. Growth Rate -- 12.03 10.82
Capital Spending - 5 Yr. Growth Rate -- 9.24 15.18

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.18 2.26
Current Ratio (MRQ) 9.02 3.43 3.08
LT Debt to Equity (MRQ) 0.00 18.73 11.38
Total Debt to Equity (MRQ) 0.00 31.43 16.13
Interest Coverage (TTM) -- -43.27 29.51

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.29 53.78
Gross Margin - 5 Yr. Avg. -- 60.55 52.17
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -110.23 12.87
Operating Margin (TTM) -- -184.42 6.20
Operating Margin - 5 Yr. Avg. -- -126.67 8.31
Pre-Tax Margin (TTM) -- -175.20 7.17
Pre-Tax Margin - 5 Yr. Avg. -- -132.83 8.61
Net Profit Margin (TTM) -- -181.93 3.30
Net Profit Margin - 5 Yr. Avg. -- -137.23 4.88
Effective Tax Rate (TTM) -- 21.48 22.88
Effective Tax Rate - 5 Yr. Avg. -- 15.57 23.39

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 7,650,695 844,239,566
Net Income/Employee (TTM) -1,634,645 652,572 100,064,145
Receivable Turnover (TTM) -- 6.25 5.72
Inventory Turnover (TTM) -- 1.89 3.48
Asset Turnover (TTM) 0.00 0.32 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -77.56 6.45 11.08
Return on Assets - 5 Yr. Avg. -- 5.52 12.21
Return on Investment (TTM) -85.13 8.99 14.48
Return on Investment - 5 Yr. Avg. -- 6.85 15.88
Return on Equity (TTM) -85.28 10.13 15.99
Return on Equity - 5 Yr. Avg. -- 8.39 17.00
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -39.54 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for SAGE Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -26.32 -28.86 4 99
13 Week -21.28 -25.12 17 95
26 Week -12.72 -19.35 37 98
52 Week 47.22 24.78 76 72
YTD 25.54 10.25 62 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 381
Total Shares Held: 49,408,631
3 Mo. Net Change: 165,347
# New Positions: 7
# Closed Positions: 7
# Increased Positions: 18
# Reduced Positions: 17
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.